Mura T

Montpellier Neuroscience Institute, INSERM U1298, Univ Montpellier, Department of Biostatistics, Epidemiology & Public Health, University Hospital Centre Nimes, Nimes, Occitanie, France.

1 preprint · 3 papers · ORCID

PreprintPsilocybin

Reduced egocentricity after psilocybin in patients with alcohol use disorder: a pilot randomized controlled trial

Bukowski H, de Timary P, Belahda D +4

Europe PMC2026

ArticlePsychedelics

Redefining the real problem in psychedelic trials: Why fighting the Lessebo matters more than blinding integrity.

Vanderijst L, Faillie JL, Mura T +1

Europe PMC2026

ArticlePsilocybin

Insights from the psychedelic experience integration session: Verbatims differentiate 3-month abstinence in alcohol use disorder with depressive symptoms.

Garcia Garcia M, Belahda D, Graux C +5

Europe PMC2026

ArticlePsilocybin

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial.

Luquiens A, Belahda D, Graux C +5

Europe PMC2025